Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Court upheld the FAS decision to impose a fine on Severstal

1/18/24 CHMF

Mosenergo increased electricity generation by 0.8% in 2023

1/18/24 MSNG

Shedevrum has made it to the top of the global ranking of State of Mobile 2024

1/18/24 YNDX

Fesco increased cabotage volume in the Far East by 5%

1/18/24 FESH

Magnit launched the first pharmacy of a new format

1/18/24 MGNT

Rusal acquires 80% of bauxite supplier JSC Timan Bauxite

1/18/24 RUAL

Artgen Biotech reported for 9 months of 2023

1/18/24 ABIO

Cosmos Hotel aims to capture 15-20% of the hotel market by 2026

1/18/24 AFKS

Whoosh intends to increase the density of coverage

1/18/24 WUSH

VTB to launch VTB Pay payment application in 2024

1/18/24 VTBR